Thursday - June 5, 2025
AstraZeneca's Record Seventh Year of Plenary Data at ASCO Furthers Ambition to Redefine Breast Cancer Care and Transform Outcomes in Gastric Cancer
May 22, 2025
WILMINGTON, Delaware, May 22 -- AstraZeneca, a biopharmaceutical company, issued the following news release on May 21, 2025:

* * *

AstraZeneca's record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer

AstraZeneca advances its ambition to eliminate cancer as a cause of death with new data across its diverse, industry-leading portfolio and pipeline at the American Society of Cl . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products